狼疮遗传负荷通过抗核抗体形成增加从正常向临床前自身免疫状态转变的风险
该研究分析349例临床前自身抗体阳性韩国个体、33596名健康对照和2057例系统性红斑狼疮患者的遗传数据,计算基于180个已知非HLA狼疮位点、HLA-DRB1经典等位基因和预设免疫通路的狼疮多基因风险评分。结果显示临床前自身免疫个体狼疮多基因风险评分显著高于健康对照,且抗核抗体滴度与评分呈显著上升趋势;评分超过年龄性别匹配狼疮患者均值的临床前个体发生抗核抗体的风险显著更高。
要点
- 临床前自身免疫个体狼疮多基因风险评分显著高于健康对照(P=2.99×10⁻⁵)。
- 抗核抗体滴度与多基因风险评分之间呈显著上升趋势(P=1.12×10⁻³)。
- 评分超过年龄性别匹配狼疮患者均值的临床前个体,在1:80稀释度下发生抗核抗体的风险显著更高(OR=2.25,P=8.12×10⁻³)。
核心结论
- 狼疮遗传负荷可能通过增加抗核抗体的易感性和水平,在致病阶段之前促使个体从正常状态向临床前自身免疫状态转变。
研究设计与样本
- 研究分析349例临床前自身抗体阳性韩国个体、33596名健康对照和2057例系统性红斑狼疮患者的遗传数据。
- 基于180个已知非人类白细胞抗原狼疮位点、HLA-DRB1经典等位基因和预设免疫相关通路计算狼疮全基因组和通路特异性多基因风险评分。
主要发现
- 临床前自身免疫个体狼疮多基因风险评分显著高于健康对照(P=2.99×10⁻⁵)。
- 抗核抗体滴度与多基因风险评分之间呈显著上升趋势(P=1.12×10⁻³)。
- 多基因风险评分超过年龄性别匹配狼疮患者均值的临床前个体,在1:80稀释度下发生抗核抗体的风险显著更高(OR=2.25,P=8.12×10⁻³)。
- 通路特异性多基因风险评分分析显示,抗核抗体阳性临床前个体中狼疮风险效应显著富集于9条通路,如活性氧产生、T细胞受体、B细胞受体和细胞因子相关信号通路(校正P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to investigate the association between the genetic burden of systemic lupus erythematosus (SLE) and the loss of tolerance to self-nuclear antigens in the preclinical stage. METHODS: We analysed genetic data from 349 Korean individuals who tested positive for autoantibodies in the preclinical stage, along with 33,596 healthy controls and 2057 patients with SLE. Genome-wide and pathway-specific polygenic risk scores (PRSs) of SLE were calculated based on 180 known non-human leukocyte antigen (non-HLA) SLE loci, HLA-DRB1 classical alleles, and predefined immune-related pathways to subsequently correlate with clinical phenotypes, particularly the presence of antinuclear antibodies (ANAs) at various titre thresholds. RESULTS: Individuals with preclinical autoimmune conditions exhibited significantly higher SLE PRSs than healthy controls (P = 2.99 × 10-5), with a significantly upward trend between ANA titres and PRS (P = 1.12 × 10-3). Stratification analysis revealed that preclinical-stage individuals with PRSs exceeding the means of age- and sex-matched PRSs among patients with SLE were at a significantly higher risk of ANA development (odds ratio = 2.25; P = 8.12 × 10-3 at a dilution factor of 1:80). Pathway-specific PRS analysis identified the significant enrichment of SLE-risk effects in nine pathways, such as signalling related to reactive oxygen species production, T cell receptor, B cell receptor, and cytokines, in ANA-positive preclinical individuals (Padjusted < 0.05). CONCLUSIONS: Our findings illustrate that the genetic burden of SLE may lead to a crucial transition from normal to preclinical autoimmune conditions prior to the pathogenic stage by increasing the susceptibility to and levels of ANAs.
引用
- Chun S, Bang SY, Kwon A, et al. Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development. Ann Rheum Dis. 2025. PMID: 39893101. doi:10.1016/j.ard.2025.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。